Jump to Navigation

Facebook Connect

User login

vClinic: Rosa Visits 2-3

The NLA is pleased to announce the new Virtual Patient Management Series (vClinicTM) program vClinic: Rosa - Visits 2 & 3. This new vClinic will address key knowledge and competency gaps for optimizing adherence to lipid-modifying therapies, in order to reduce the risk of morbidity and mortality from cardiovascular disease and related cardiometabolic conditions. The goal of this adherence vClinic is to provide learners with a practical framework to 1) improve patient adherence to lipid lowering therapies, including the diagnosis and treatment of statin intolerant patients; and 2) to overcome barriers to due statin intolerance, perceived risk for side effects, and/or treating existing side effects.

 

The NLA vClinic is an ideal environment to explore strategies to improve patient adherence to lipid therapy because the format replicates real-world patient encounters, enabling learners to assess and manage virtual patients, interact with peers and subject matter experts, and manage virtual patients across multiple visits and care settings.

Accreditation Information

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Content Domain
This activity falls under the following content domain(s):

  • 7.3.13 Medication Adherence
  • 7.3.14 Management of Statin Intolerance

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Demonstrate improvement in getting patients to lipid goals aligned with performance indicators
  2. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families
  3. Identify contributing factors and implications of nonadherence to lipid-lowering therapies in light of recent findings, and with a focus on recognizing cultural disparities
  4. Identify the frequency and secondary causes of statin intolerance and treatment options for statin-intolerant patients
  5. Implement strategies for the entire patient care team to improve patient adherence to lipid-modifying therapies



by Dr. Radut.